Aurobindo Pharma has inked a binding offer to acquire commercial operations in seven Western European countries from Actavis plc. The closing of the transaction is conditional on certain antitrust approvals and completion of employee consultation processes. The company expects to acquire personnel, commercial infrastructure, products, marketing authorizations and dossier license rights in seven European countries.
For more information call- 0731-6642300 or Visit-http://goo.gl/g55v85
0 comments:
Post a Comment